Related references
Note: Only part of the references are listed.Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Jessica Walsh et al.
BRAIN (2021)
Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration
Maria Victoria Chacon-Quintero et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia
Carl Eckerstrom et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of beta-Amyloid Precursor Protein in Cerebral Vasculature
Emma Ristori et al.
FRONTIERS IN PHYSIOLOGY (2020)
The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation
Christian Tackenberg et al.
MOLECULAR BRAIN (2019)
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking
Jean-Michel Paumier et al.
FASEB JOURNAL (2019)
APP-derived peptides reflect neurodegeneration in frontotemporal dementia
Ignacio Illan-Gala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease
Anders Wallin et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease
C. Eleana Zhang et al.
NEUROLOGY (2017)
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
Daniel Alcolea et al.
NEUROLOGY (2017)
Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study
Joanna M. Wardlaw et al.
ALZHEIMERS & DEMENTIA (2017)
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up
Anders Wallin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Consensus statement for diagnosis of subcortical small vessel disease
Gary A. Rosenberg et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Alzheimer's diseasesubcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
Anders Wallin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort
Olivia Anna Skrobot et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers
Ralf G. Rempe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
Jochim Reinert et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease
Peter Hermann et al.
PLOS ONE (2014)
Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy
Maria Bjerke et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2014)
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw et al.
LANCET NEUROLOGY (2013)
Functions of Aß, sAPPa and sAPPß: similarities and differences
Stephanie Chasseigneaux et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease
Jeroen D. C. Goos et al.
NEUROBIOLOGY OF AGING (2012)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
Per Johansson et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Secreted Amyloid Precursor Protein β and Secreted Amyloid Precursor Protein α Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway
Stephanie Chasseigneaux et al.
PLOS ONE (2011)
Matrix Metalloproteinases Are Associated With Increased Blood-Brain Barrier Opening in Vascular Cognitive Impairment
Eduardo Candelario-Jalil et al.
STROKE (2011)
Blood brain barrier function in vascular dementia
A. Wallin et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease
Erik Portelius et al.
ACTA NEUROPATHOLOGICA (2010)
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study
M. Jonsson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
Per Selnes et al.
FLUIDS AND BARRIERS OF THE CNS (2010)
Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment
Maria Bjerke et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Blood-brain barrier: Ageing and microvascular disease-systematic review and meta-analysis
Andrew J. Farrall et al.
NEUROBIOLOGY OF AGING (2009)
[11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients
Marie M. Svedberg et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Independent generation of Aβ42 and Aβ38 peptide species by γ-secretase
Eva Czirr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
No association between the alpha 2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
K Blennow et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia
A Wallin et al.
EUROPEAN NEUROLOGY (2000)
Share Paper
